Thoracoscopic localization of intraparenchymal pulmonary nodules using direct intracavitary thoracoscopic ultrasonography prevents conversion of VATS procedures to thoracotomy in selected patients  by Khereba, Mohamed et al.
G
T
S
General Thoracic Surgery Khereba et alThoracoscopic localization of intraparenchymal pulmonary nodules
using direct intracavitary thoracoscopic ultrasonography prevents
conversion of VATS procedures to thoracotomy in selected patientsMohamed Khereba, MD, Pasquale Ferraro, MD, Andre Duranceau, MD, Jocelyne Martin, MD, MSc,
Eric Goudie, Vicky Thiffault, BScN, and Moishe Liberman, MD, PhDFrom th
l’Uni
Cente
Support
Gosse
Disclosu
Read at
gery,
Receive
for pu
Address
partm
scopi
rue S
Queb
0022-52
Copyrig
http://dx
1160Objectives: To investigate the feasibility, accuracy, and effect on conversion rates of intracavitary video-assisted
thoracoscopic surgery ultrasonography (VATS-US) for localization of difficult to visualize pulmonary nodules.
Methods: The study consisted of a prospective cohort of VATS-US for localization of intraparenchymal
peripheral pulmonary nodules. Patients with pulmonary nodules not touching the visceral pleura on the
computed tomography scan, who were scheduled for VATS wedge resection, were prospectively enrolled.
The lobe of interest was examined: visually, using finger palpation when possible, and using the instrument
sliding method. The nodule was then sought using a sterile ultrasound transducer. The primary outcome
measure was the prevention of conversion to thoracotomy or lobectomy secondary to positive VATS-US
findings in patients with nodules that were not identifiable using standard VATS techniques.
Results: Four different surgeons performed 45 individual VATS-US procedures during a 13-month period. Intra-
cavitary VATS-US was able to detect 43 of 46 nodules. The sensitivity of VATS-US was 93%, and the positive
predictive value was 100%. The lung nodules were visualized by thoracoscopic lung examination in 12 cases
(27%), palpable by finger in 18 cases (40%), and palpable using the instrument sliding technique in 17 cases
(38%). In 20 cases, lung nodules were not identifiable using any of the traditional techniques and were
identified only with VATS-US. VATS-US, therefore, prevented conversion to thoracotomy or lobectomy
without tissue diagnosis in 43% (20/46) of cases.
Conclusions: Intracavitary VATS-US is a real-time, feasible, reliable, and effective method of localization of
intraparenchymal pulmonary nodules during selected VATS wedge resection procedures and can decrease the
conversion rates to thoracotomy or lobectomy. (J Thorac Cardiovasc Surg 2012;144:1160-6)Thoracoscopic, nonanatomic wedge resection of nonsub-
pleural pulmonary nodules remains a challenge. This chal-
lenge is amplified when the nodules are small and/or deep in
the pulmonary parenchyma. Video-assisted thoracoscopic
surgery (VATS) has become the standard of care for resec-
tion of indeterminate pulmonary nodules for diagnosis, as
the treatment of choice for pulmonary metastases, and for
resection of primary lung cancer in selected high-risk
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The Journal of Thoracic and Cardiovascular SurTraditional VATS techniques do not allow for bimanual
lung palpation, making finding the nonsubpleural pulmonary
nodule difficult. This is in sharp contrast to the open (thoracot-
omy) technique, which allows for bimanual palpation of the
lung parenchyma and, therefore, typically, simple localization
of nodules. Failure to localize small and relatively deep pul-
monary nodules often leads to conversion to open thoracot-
omy. Conversion rates have been reported to be as great as
59%.3-5 Various preoperative and intraoperative techniques
have been described for nodule localization during VATS.
These techniques have included hook wire insertion,
methylene blue injection, metallic coil insertion,
technetium-99–labeled human serum albumin microspheres,
and radiotracer-guided thoracoscopic biopsy.6-12
VATS-ultrasonography (VATS-US) is a simple, safe, and
real-time method of pulmonary nodule localization during
VATS procedures. We hypothesized that VATS-US could
decrease the rate of conversion to thoracotomy in patients
undergoing VATS wedge resection for small, nonsubpleural
pulmonary nodules. The aims of the present study were to
describe the sensitivity and specificity of VATS-US com-
pared with traditional VATS techniques and the ability of
VATS-US to prevent conversion to thoracotomy in patients
with nodules not localized using traditional techniques.gery c November 2012
Abbreviations and Acronyms
CT ¼ computed tomography
VATS ¼ video-assisted thoracoscopic surgery
VATS-US ¼ video-assisted thoracoscopic surgery
ultrasonography
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SMATERIALS AND METHODS
The present study was a prospective clinical trial (clinicaltrials.gov
identifier NCT01201824) evaluating VATS-US in a cohort of patients
with nonsubpleural parenchymal pulmonary nodules. Each patient served
as their own control. The primary outcome measure was the assessment
of the validity, feasibility, and safety of surgeon-performed intraoperative
intracavitary US as a localization technique for difficult to visualize pulmo-
nary nodules during VATS procedures. The main secondary outcome was
the ability of VATS-US to decrease the conversion rates of VATS proce-
dures to open thoracotomy.
Other secondary outcomes included the following:
To compare the efficacy of VATS-US with other operative localization
techniques for small pulmonary nodules during VATS (ie, visual
localization, finger palpation, and the instrument sliding method).
To assess the ability of VATS-US to differentiate malignant versus be-
nign pulmonary nodules using the US properties of the nodules.
To assess the ability of intraoperative intracavitary US to detect new
pulmonary nodules, not detected on the preoperative computed
tomography (CT) scan.
The institutional review board at the Centre de Recherche de l’Uni-
versite de Montreal approved the study. We screened all patients scheduled
for VATS wedge resection for solitary or multiple pulmonary nodules. El-
igible patients included those with CT scan-identified pulmonary nodules
that were nonsubpleural (lung tissue between the nodule and visceral
pleura on the preoperative CT scan) who were candidates for VATS resec-
tion. Patients with pulmonary nodules believed to be easily localized dur-
ing VATS (large size, pleural retraction) were excluded from the present
study. The eligible patients were prospectively enrolled after providing
written informed consent.
The preoperative CT scan was used to record the size, site, and charac-
teristics of the pulmonary nodules of interest and was used for comparison
with the recorded values from the intraoperative VATS-US. The procedure
date of the preoperative CT scan was recorded to calculate the interval
between CT and VATS-US examination.
All procedures were performed with the patient under general anesthe-
sia with single lung ventilation through double-lumen endotracheal intuba-
tion. Patient positioning, surgical preparation, and all surgical incisions
were performed according to the standard VATS procedure of the surgeon
performing the procedure. The surgeons were counseled not to change their
typical VATS incisions (incision length, port size, position of incision) to
accommodate the VATS-US probe or the angulation of the probe onto
the lung.
After VATS port placement, the lung was completely deflated, and pleu-
roscopy was performed, searching for the nodule of concern using video
thoracoscopy alone. The surgeon then tried to localize the nodule by finger
palpation and then using the instrument sliding method.
A sterile, intracavitary, 10-mm VATS-US 5- to 10-MHz linear probe
with a flexible angulating tip (Aloka UST-5536-7.5; Hitachi Aloka
Medical, Ltd, Hitachi, Japan; Figure 1) attached to an US processor (Aloka
Alpha 10) was introduced through 1 of the VATS ports. The VATS-US
examination was performed on the affected pulmonary lobe, attempting
to localize the nodules of interest. Endoscopic articulation of the VATS-
US probe often helps to identify nodules in more posterior or inferiorThe Journal of Thoracic and Carlocations. Sterile US jelly or water was used to help localize nodules not
easily located with the initial US attempts.
The nodules were localized by direct US visualization of the nodule of
concern (Figure 2) with or without the presence of a hyperechoic shadow
underneath the nodulewithin the lung parenchyma (Figure 3). After nodule
localization, the US properties, including size, distance from pleura, echo-
genicity, shape, sharpness of borders, and vascularity by Doppler examina-
tion, were recorded. After nodule localization, VATS wedge resection was
performed. The resected lung tissue was macroscopically examined by the
surgeon in the operating room to identify the resected lung nodules before
sending the specimen for frozen section examination. In patients in whom
the nodule of interest was not identified using any of the standard VATS
techniques or by VATS-US, open thoracotomy was performed.
Four general thoracic surgeons performed or supervised all procedures
in the present study. Three of these surgeons had no formal training in US or
experience with US before the present study.
All final pathologic reports were reviewed to confirm the presence of the
nodule of interest in the resected specimen and its nature. The pathologic
reports were also reviewed for surgical margin status.
RESULTS
During a 13-month period (September 2010 to October
2011), 43 patients, including 21 men and 22 women, were
prospectively enrolled in the present study. Patient age
ranged from 28 to 88 years (mean, 57.7). VATS-US was
used in 45 procedures. Two patients underwent surgery
twice during the study, on bilateral sides, at an interval of
3 and 4 months. One patient underwent surgery for 2 nod-
ules on the same side. Each of the 2 nodules was evaluated
using VATS-US, and the patient underwent 2 VATS resec-
tions during the same procedure. The procedure indications
included 34 performed for a preoperative diagnosis of
a solitary pulmonary nodule, 10 for multiple pulmonary
nodules, and 1 for a bronchogenic cyst.
The procedural time ranged from 24 to 163 minutes
(mean, 73.4 34.0). Nomajor intraoperative complications
occurred.
The mean interval between the preoperative CT scan and
procedure was 84 days (median, 71). A total of 46 nodules
were examined using VATS-US: 14 in the right lower
lobe; 10, right upper lobe; 2, right middle lobe; 10, left upper
lobe; and 10, left lower lobe. ThemeanVATS-US–measured
dimensions were 11.3 mm in the long axis (range, 2.7-27.7)
and 8.6 mm in the short axis (range, 2-20.4). The distance
from the visceral pleura was 1 to 24.1 mm (Table 1).
The site of all nodules found using VATS-US correlated
with the preoperative CT scan findings. No additional nod-
ules were identified by VATS-US that were not found on the
preoperative CT scan.
Intracavitary VATS-US was able to detect 43 (93.5%) of
46 nodules. VATS-US was unable to localize 3 pulmonary
nodules (Table 2). The VATS-US procedural time ranged
from less than 1 to 13 minutes (mean, 4.07  3.99).
Of the 3 patients with nondetectable pulmonary nodules
using VATS-US, 1 had Hodgkin’s lymphoma with multiple
indeterminate pulmonary nodules. The lung parenchyma
was extremely edematous and thick, and the nodules werediovascular Surgery c Volume 144, Number 5 1161
FIGURE 1. Intracavitary, 10-mm video-assisted thoracoscopic surgery
ultrasonography, 5- to 10-MHz linear probe with a flexible angulating tip
(Aloka UST-5536-7.5).
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fiable using VATS observation, finger palpation, or the
instrument sliding technique. In this patient, blind wedge
resection was performed using the preoperative CT scan im-
ages, and a nodule was found in the specimen. Pathologic
examination confirmed the presence of the nodule, with
a histologic diagnosis of pulmonary Hodgkin’s lymphoma.
One nodule that was not visible by VATS examination nor
by VATS-US, was, however, palpable using finger palpa-
tion. The third nodule was extremely difficult to examine
using VATS-US owing to a very posterior location very
close to the spine. Because of the high probability of
malignancy in the nodule (by CT and positron emission
tomography scans), VATS lobectomy was performed. The
nodule was easily detected using VATS-US ex vivo. In 1
patient, single lung ventilation was not possible owing to
hypoxia. In this patient, VATS-US was able to localize the
pulmonary nodule without lung isolation.FIGURE 2. A, Small, 10-mm pulmonary nodule (arrow) located in the right lo
video-assisted thoracoscopic surgery ultrasound in vivo image of the nodule.
1162 The Journal of Thoracic and Cardiovascular SurThe sensitivity of VATS-US was 93.5%, and the positive
predictive value was 100%. Lung nodules were visualized
by thoracoscopic lung examination in 12 cases (27%), pal-
pable by finger in 18 nodules (40%), and palpable using the
instrument sliding technique in 17 nodules (38%). Overlap
was present because some nodules were localizable using
more than 1 technique. The mean CT scan diameter for
the 20 lesions not detected using standard intraoperative
techniques was 14.5 mm (long axis) and 12.3 mm (short
axis). The mean distance from the pleura was 11.0 mm.
Figure 4 compares the VATS localization technique ability
to identify the nodule of interest in the study cohort.
The results were confirmed by pathologic examination,
with negative margins in 100% of the pulmonary wedge re-
sections. Pathologic analysis of the resected 46 nodules
confirmed the presence of 31 malignant and 15 benign nod-
ules. No significant differences were seen between the
echogenic properties and final pathologic findings of the
resected nodules (Table 3).
In 20 procedures (20 nodules), the lung nodules were not
identifiable using any of the standard VATS techniques and
were only found using VATS-US. VATS-US, therefore,
prevented conversion to thoracotomy or lobectomy without
tissue diagnosis in 43.5% (20/46) of cases. Furthermore,
VATS-US confirmed nodule location before wedge resec-
tion in cases in which the location of the nodule was be-
lieved to be identified using traditional techniques.DISCUSSION
VATS-US allows fast, real-time, and sensitive pulmonary
nodule localization. It has the advantage of not requiring
preoperative localization techniques and is, therefore,
more convenient, efficient, safe, and less costly than tech-
niques that require a separate procedure before VATS for
nodule localization. It also avoids the logistical issues
with the timing of multiple procedures and, in the presentwer lobe on preoperative computed tomography image. B, Corresponding
gery c November 2012
FIGURE 3. A, Preoperative computed tomography image of small, irregular, left upper lobe ground glass opacity with solitary components (arrow). B,
Corresponding video-assisted thoracoscopic surgery ultrasound in vivo image of the nodule.
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VATS-US does not require the adaptation or elongation of
standard VATS incisions in any way.
The present study was not designed to demonstrate the
superiority of VATS-US compared with invasive preopera-
tive localization techniques (eg, hook wire insertion, meth-
ylene blue, bronchoscopic nodule tagging). It was designed
to demonstrate the sensitivity of VATS-US compared with
standard VATS techniques without preoperative localiza-
tion and to evaluate the ability of VATS-US to prevent
conversion to thoracotomy in patients with nodules not
localizable using standard VATS techniques.
Although preoperative methods of nodule localization
have been shown to be effective and relatively safe in
several studies, they are still not devoid of risk. Reported
complications have included pneumothorax and pulmonary
hemorrhage.6,13,14 Technical difficulties can lead to failure
of hook wire placement. The wire can also be misplaced
(improper insertion placement).15 The site of methylene
blue injection can be far from the site of the nodule, or,
more commonly, the stain is either not visible after injection
or has spread and stained a large portion of normal lung
surrounding the lesion, preventing nodule localization.10
Migration of the coil in the lung parenchyma during the
period between coil insertion and operative resection can
occur in 3% to 10%, leading to failure of localization if
the displacement is more than 10 mm from the nodule of
concern.9,16,17
In completely deflated lungs, the structures of the pulmo-
nary arterioles and venules are identified as homogeneous
hypoechoic areas, and the bronchioles appear as hypere-
choic spots, in the vicinity of the pulmonary arterioles.
The nodule of interest is identified by US visualization of
a hyper- or hypoechoic nodule or by visualization of a hy-
perechoic shadow beneath the nodule. This technique can
be performed without the use of any other identifying
methods and is less cumbersome and expedient.18The Journal of Thoracic and CarUsing the high-quality imaging of US guidance to iden-
tify small and deep nodules, a strong correlation exists
between resection margins measured using US, with the
margins verified by histologic examination in the resected
lung specimens.18
Intracavitary US has been shown to be able to identify
very small pulmonary nodules down to 4 mm in diameter
and even nodules deeply situated in the lung parenchyma.19
In the present study, we were able to localize small nodules,
down to 2 mm using USmeasurement. The detection rate of
pulmonary nodules has been shown to be much greater us-
ing VATS-US compared with video visualization or finger
palpation.20,21 This was confirmed in the present study,
with 27% of lung nodules detected by VATS visualization
and 40% by finger palpation. This compares with 93.5%
of lung nodules detected using VATS-US examination.
The efficacy of US is manifested by comparison with the
number and size of the nodules identified using high-
resolution CT images preoperatively. Furthermore, in 1
study, US could identify 2 new small nodules not identified
before using spiral CT.22 In the present study, we were un-
able to localize any nodules not identified on the preopera-
tive CT scan. However, the goal was to find the nodule of
interest and not other nodules; therefore, minimal time
was spent searching for other nodules not identified on
the preoperative CT scan.
Intracavitary US characteristics have been shown to cor-
relate with probability of malignancy in published data.20-24
We were, however, unable to confirm these findings in the
present study. This was probably secondary to the sample
size in our study being too small to appreciate an
association between the probability of malignancy and the
US characteristics of the nodules.
VATS-US has been shown to be an extremely safe and
effective method of pulmonary nodule detection. No associ-
ated complications have been reported with VATS-US.21
Our study has confirmed these findings.diovascular Surgery c Volume 144, Number 5 1163
TABLE 2. VATS-US results versus final pathologic results for nodules
of interest
VATS-US result
Pathologic finding
Positive Negative
Positive 43 (TP) 0 (FP)
Negative 3 (FN) 0 (TN)
VATS-US, Video-assisted thoracoscopic surgery ultrasonography; TP, true positive;
FP, false positive; FN, false negative; TN, true negative.
TABLE 1. Lesion size and corresponding distance from pleura
Finding
VATS-US
measurement (mm)
CT scan
(distance from
pleura; mm)
Pathologic
measurement (mm)
Short axis Long axis Short axis Long axis
Positive 2 3.7 14 6 6
Positive 2.3 2.7 3 4 8
Positive 2.5 5.6 1.3 8 8
Positive 2.9 3.2 2 8 10
Positive 2.9 15.8 1 8 15
Positive 3.1 5.8 3 4.5 4.5
Positive 3.6 5 7.5 5 7
Positive 3.6 4.2 1 5 5
Positive 3.6 5.1 18 24 25
Positive 4.7 5.7 9.6 8 8
Positive 5.4 8.8 15.3 8 8
Positive 6.3 6.4 20 6 6
Positive 6.9 9.4 24.1 16 18
Positive 7.6 7.8 1.4 10 10
Positive 7.6 9.4 4 10 13
Positive 7.8 8 2 5 6
Positive 8 8 14.5 6 7
Positive 8.3 15.7 1 12 12
Positive 8.5 9.4 23.1 10 15
Positive 8.5 11 10.6 20 22
Positive 8.6 9.1 4.7 8 8
Positive 8.6 8.7 5 10 10
Positive 8.7 14 1 13 13
Positive 8.8 8.9 1 15 20
Positive 8.9 15.8 5.4 14 16
Positive 8.9 10.2 8.7 10 10
Positive 9 6.4 2 10 10
Positive 9.1 15.4 1 11 11
Positive 9.4 15.7 6.5 15 16
Positive 10.1 12.6 5 8 15
Positive 10.8 12.24 14 15 15
Positive 10.8 13 13 15 20
Positive 11.1 11.9 4.6 15 18
Positive 11.5 13.4 15 13 17
Positive 12.1 14.3 10.9 15 21
Positive 12.1 14.1 14.7 10 11
Positive 12.3 15.9 15.7 15 18
Positive 12.3 24.8 12.5 25 30
Positive 12.9 16.3 4.2 11 13
Positive 14.1 14.7 12.2 15 20
Positive 14.4 15.5 11 10 18
Positive 19.2 25.5 9.5 20 62
Positive 20.4 27.7 3 10 15
Negative NA NA 17.6 8 7
Negative NA NA 10.6 1 5
Negative NA NA 9 2 2
VATS-US, Video-assisted thoracoscopic surgery ultrasonography; CT, computed to-
mography; NA, not available.
FIGURE 4. Comparison of video-assisted thoracoscopic surgery localiza-
tion technique’s ability to identify nodules of interest.
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shown by others to be short (approximately 7.5 minutes).
However the logistical issues of waiting for a radiologist
and the time it takes for the radiologist to come to the1164 The Journal of Thoracic and Cardiovascular Suroperating room make this option less desirable.25 This can
be avoided if the surgeon is the ultrasonographer. US expe-
rience is not a necessary prerequisite for performing VATS-
US, and 4 different thoracic surgeons and multiple residents
and fellows localized the nodules in the present study.
VATS-US is a simple technique, with a rapid learning curve,
manifested by a rapid decrease in the time necessary for the
US examination after the first few cases to reach an average
of 4 minutes.
The most important finding in the use VATS-US in the
present study was its role in preventing conversions from
VATS to open thoracotomy. In 20 cases, lung nodules
were not identifiable using any of the traditional tech-
niques and were identified only with VATS-US. VATS-
US, therefore, prevented conversion to thoracotomy or
lobectomy without tissue diagnosis in 43.5% of the
cases.CONCLUSIONS
Surgeon-performed intracavitary VATS-US offers
a real-time, simple, and effective technique for localiza-
tion of difficult to visualize nonsubpleural pulmonary nod-
ules. This technique is completely safe and without any
complications. Moreover, it can prevent imminent conver-
sion to open thoracotomy during selected VATS wedge
resection.gery c November 2012
TABLE 3. Ultrasound characteristics of nodules examined using
VATS-US and their relationship to pathologic nature of nodule
Characteristic Malignant Benign
Shape
Round 10 8
Oval 11 2
Irregular 8 4
Borders
Ill defined 16 6
Well defined 13 8
Echogenicity
Hyperechoic 3 1
Medium 9 5
Hypoechoic 17 8
Doppler
Positive 5 1
VATS-US, Video-assisted thoracoscopic surgery ultrasonography.
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Dr Bryan Fitch Meyers (St Louis, Mo). I enjoyed your presen-
tation and I have a couple of questions to stimulate discussion.
You mentioned that US was used in each case here, but in the
range of sizes of the lesions you described, I saw a 51-mm lesion
and a 27-mm lesion. I would argue that you really do not need US
to find a 5-cm or a nearly 3-cm lesion in the lung. In this case, you
were trying to use it broadly andmight have used it inmany instances
in which it absolutely was not needed. Can you comment on that?
Dr Khereba. There was only 1 case with a 51-mm nodule; ac-
tually, it was found to be a bronchogenic cyst. According to the
surgeon and because of the centrality of this nodule, he thought
that it might be difficult to find this nodule using finger palpation
or instrument sliding. It was not visible during the study, but it was
found by finger palpation and instrument sliding, and US as well.
For the other nodules, the 20 cm or 27 cm, that was 2 or 3 cases in
the study, and they were deeper into the lung parenchyma.
We chose our nodules according to the choice of the surgeon.
We revised the nodules; however, if the surgeon needs US to be
performed, he asks for the US.
Dr Charles R. Bridges (Charlotte, NC). It is important to point
out that the mean diameter long axis was only 13 mm. So, that 51
mm was clearly an outlier.
DrKhereba. It is only 1 nodule that has been passing our mean;
most of the nodules were between 5 and 50 mm.
Dr Meyers. I agree, and I understand that you are making
a point here and you are demonstrating the potential utility of
a new technology, but in terms of actual clinical use, if the mean
is 13 mm, that means one half of the lesions are larger than that,
and generally the challenge is with the subcentimeter lesion.
Therefore you would argue that perhaps one half of these lesions
used in this demonstration trial would really be a challenge to
find. So, the broad utility of something like this might need to be
focused slightly more on the most challenging lesions.diovascular Surgery c Volume 144, Number 5 1165
General Thoracic Surgery Khereba et al
G
T
SDr Khereba. Thank you for your question. I think that in pub-
lished studies, it was proven that the conversion rate is greater for
lesions either less than 10mm ormore than 1 cm in the depth of the
lung.
Thank you.
Dr Chumy Nwogu (Buffalo, NY). I have 3 questions for you.
This was a very interesting presentation, and I am looking forward
to using it in my practice. However, I was wondering what the
source of the data on the other techniques is, whether you were
just comparing your US findings with results from previously pub-
lished studies. Were you studying the comparative results of these
techniques in your own patients with similar lesion sizes, a similar
depth from the surface?
Dr Khereba. Yes, exactly. You mean the intraoperative finger
palpation and instrument sliding?
Dr Nwogu. Yes.
DrKhereba. For every case, we performed finger palpation, in-
strument sliding, and VATS-US.
Dr Nwogu. I was wondering whether you had some patients
with very severe chronic obstructive pulmonary disease in whom
the lung was not completely deflated. In those cases, was it more
difficult for you to apply the US in that situation?
Dr Khereba.We did not have any difficulty with emphysema-
tous patients. We had 1 case actually in which we could not
achieve complete lung deflation, and we still found the nodule
using US.1166 The Journal of Thoracic and Cardiovascular SurDr Nwogu. So the air does not interfere at all with your
visualization?
Dr Khereba. It is more difficult to find the nodules in emphy-
sematous patients. However, all our population that was examined,
most of them were already emphysematous, but we did not have
difficulty with that.
Dr Nwogu. There were about 3 cases in which you could not
localize the lesion using your technique. What do you think
were the causes of failure in those cases?
Dr Khereba. We had 3 cases. The first case was a patient in
whom there were multiple pulmonary nodules and we could not
find the nodules using any other method, and it was impossible
to examine the lung because it was not echogenic at all. Thus,
because of the multiple pulmonary nodules, we performed a blind
incision and VATS resection, and we found a nodule. Finally, it
turned out to be Hodgkin’s lymphoma.
The other nodule was difficult to find, because it was so poste-
rior into the lung and proximal to the spine, and we could not find it
using US in this position. Finally, because of its high probability on
positron emission tomography scan and CT scan, we performed
a lobectomy on this patient, and we found the nodule in vitro using
US. However, we still considered that as a negative result.
The third nodule was examined using US, and we could not find
the nodule, but we still found it by finger palpation. We readminis-
tered US on the nodule, andwe could not find it. So, we finally con-
sidered that a negative result as well.gery c November 2012
